|
ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs.
We apply new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identify proprietary and related molecules for better patient treatment.
Recent Releases
Mar 8, 2010
ZIOPHARM Oncology to Present at the 22nd Annual Roth OC Growth Stock Conference
Mar 4, 2010
ZIOPHARM Oncology to Present at the Cowen and Company 30th Annual Health Care Conference
more »
Events
Mar 15, 2010
ZIOPHARM Oncology to Present at the 22nd Annual Roth Growth Conference
Mar 11, 2010
ZIOPHARM Oncology to Present at the Cowen and Company 30th Annual Health Care Conference
more »
| 
